Table 1 Patient demographics and baseline disease characteristics (N = 13 patients)

Age, years; median

50 (range 40–81)

Cutaneous primary

11 (84)

Mucosal primary

1 (8)

Unknown primary

1 (8)

Gender

 Female

3 (23)

 Male

10 (77)

Performance status (ECOG)

 0

10 (77)

 1

3 (23)

Stage

 IIIB

1 (8)

 IIIC

12 (92)

Tumor mutational status

 BRAF^V600

6 (46)

 NRAS^Q61

2 (15)

 NRAS^R73

1 (8)

 BRAF/NRAS WT

3 (23)

 Unknown

1 (8)